
| ROI Name | ∑ In  | % In  | log ratio  | ∑ Out  | % Out  | 
|---|---|---|---|---|---|
| PB | 522 | 52.4% | 1.80 | 1,814 | 91.3% | 
| CRE_R | 196 | 19.7% | -1.16 | 88 | 4.4% | 
| EB | 158 | 15.9% | -1.98 | 40 | 2.0% | 
| NO | 61 | 6.1% | -2.35 | 12 | 0.6% | 
| FB | 41 | 4.1% | -1.90 | 11 | 0.6% | 
| SPS_L | 5 | 0.5% | 1.00 | 10 | 0.5% | 
| BU_R | 9 | 0.9% | -1.17 | 4 | 0.2% | 
| ICL_L | 0 | 0.0% | inf | 6 | 0.3% | 
| IB_L | 4 | 0.4% | -2.00 | 1 | 0.1% | 
| upstream partner  | # | NT | conns EPGt  | % In  | CV | 
|---|---|---|---|---|---|
| Delta7 (R) | 5 | Glu | 108.5 | 24.7% | 0.5 | 
| EPG (L) | 7 | ACh | 67.5 | 15.4% | 1.2 | 
| P6-8P9 (L) | 2 | Glu | 46 | 10.5% | 0.1 | 
| ExR6 (R) | 1 | Unk | 27 | 6.1% | 0.0 | 
| EPGt (L) | 2 | ACh | 20 | 4.6% | 0.1 | 
| LPsP (L) | 1 | Unk | 19 | 4.3% | 0.0 | 
| LPsP (R) | 1 | ACh | 14.5 | 3.3% | 0.0 | 
| PEN_b(PEN2) (R) | 1 | Unk | 10.5 | 2.4% | 0.0 | 
| ER3p_a (R) | 6 | GABA | 10.5 | 2.4% | 0.7 | 
| Delta7 (L) | 3 | Glu | 9 | 2.0% | 0.8 | 
| PEN_a(PEN1) (L) | 2 | ACh | 9 | 2.0% | 0.1 | 
| ER3p_a (L) | 8 | GABA | 9 | 2.0% | 0.5 | 
| PEN_b(PEN2) (L) | 1 | Unk | 8 | 1.8% | 0.0 | 
| EPG (R) | 2 | ACh | 8 | 1.8% | 0.5 | 
| PEN_a(PEN1) (R) | 3 | ACh | 7 | 1.6% | 0.8 | 
| ER1 (L) | 6 | GABA | 6.5 | 1.5% | 0.8 | 
| ExR6 (L) | 1 | Glu | 6 | 1.4% | 0.0 | 
| OA-AL2i1 (L) | 1 | OA | 5.5 | 1.3% | 0.0 | 
| hDeltaB (R) | 1 | ACh | 5 | 1.1% | 0.0 | 
| ER3w (R) | 5 | GABA | 4.5 | 1.0% | 0.4 | 
| ER1 (R) | 4 | GABA | 4 | 0.9% | 0.5 | 
| ER3w (L) | 2 | GABA | 3.5 | 0.8% | 0.1 | 
| PEG (L) | 3 | ACh | 2.5 | 0.6% | 0.6 | 
| hDeltaG (R) | 1 | ACh | 2 | 0.5% | 0.0 | 
| ExR1 (R) | 1 | Unk | 2 | 0.5% | 0.0 | 
| FB1H (R) | 1 | DA | 1.5 | 0.3% | 0.0 | 
| ExR5 (R) | 2 | Glu | 1.5 | 0.3% | 0.3 | 
| SMP371 (R) | 1 | Glu | 1.5 | 0.3% | 0.0 | 
| FB4R (L) | 2 | Glu | 1.5 | 0.3% | 0.3 | 
| SpsP (L) | 2 | Glu | 1.5 | 0.3% | 0.3 | 
| hDeltaI (R) | 1 | ACh | 1 | 0.2% | 0.0 | 
| ExR1 (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| ExR5 (L) | 2 | Glu | 1 | 0.2% | 0.0 | 
| PFNp (L) | 2 | Unk | 1 | 0.2% | 0.0 | 
| PFNv (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| PFNd (R) | 1 | ACh | 1 | 0.2% | 0.0 | 
| ExR4 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| IbSpsP (L) | 2 | ACh | 1 | 0.2% | 0.0 | 
| vDeltaM (R) | 2 | ACh | 1 | 0.2% | 0.0 | 
| FB4Y (R) | 2 | Unk | 1 | 0.2% | 0.0 | 
| ExR4 (R) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| cM11 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| FB4M (R) | 1 | DA | 0.5 | 0.1% | 0.0 | 
| FB4Y (L) | 1 | Unk | 0.5 | 0.1% | 0.0 | 
| FC3 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| PFNd (L) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| PEG (R) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| hDeltaA (R) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| ER3m (R) | 1 | GABA | 0.5 | 0.1% | 0.0 | 
| hDeltaB (L) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| hDeltaA (L) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| DNpe037 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| ER6 (R) | 1 | GABA | 0.5 | 0.1% | 0.0 | 
| CB0663 (R) | 1 | Glu | 0.5 | 0.1% | 0.0 | 
| downstream partner  | # | NT | conns EPGt  | % Out  | CV | 
|---|---|---|---|---|---|
| PEG (L) | 1 | ACh | 86.5 | 20.4% | 0.0 | 
| PFNd (L) | 2 | ACh | 79.5 | 18.8% | 0.0 | 
| PEN_b(PEN2) (L) | 3 | ACh | 29.5 | 7.0% | 0.7 | 
| PEN_a(PEN1) (L) | 1 | ACh | 20.5 | 4.8% | 0.0 | 
| EPGt (L) | 2 | ACh | 20 | 4.7% | 0.0 | 
| Delta7 (R) | 7 | Glu | 19.5 | 4.6% | 0.7 | 
| PFNp (L) | 13 | ACh | 18.5 | 4.4% | 1.0 | 
| LPsP (L) | 1 | Unk | 18 | 4.3% | 0.0 | 
| PFNa (L) | 2 | ACh | 17.5 | 4.1% | 0.1 | 
| IbSpsP (L) | 3 | ACh | 17.5 | 4.1% | 0.6 | 
| Delta7 (L) | 9 | Glu | 16 | 3.8% | 1.1 | 
| LPsP (R) | 1 | ACh | 15 | 3.5% | 0.0 | 
| PFNv (L) | 1 | ACh | 13 | 3.1% | 0.0 | 
| PFNm (L) | 6 | ACh | 11 | 2.6% | 0.6 | 
| EPG (L) | 3 | ACh | 6 | 1.4% | 0.4 | 
| ExR6 (R) | 1 | Unk | 5.5 | 1.3% | 0.0 | 
| ExR1 (R) | 2 | Unk | 4 | 0.9% | 0.2 | 
| ExR4 (L) | 1 | ACh | 3 | 0.7% | 0.0 | 
| EL (L) | 3 | GABA | 3 | 0.7% | 0.7 | 
| PFGs (L) | 2 | Unk | 2 | 0.5% | 0.5 | 
| ExR1 (L) | 1 | GABA | 1.5 | 0.4% | 0.0 | 
| EL (R) | 2 | GABA | 1.5 | 0.4% | 0.3 | 
| ER6 (R) | 1 | GABA | 1 | 0.2% | 0.0 | 
| ExR6 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| EPG (R) | 2 | ACh | 1 | 0.2% | 0.0 | 
| FC2C (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| FS4A (L) | 2 | ACh | 1 | 0.2% | 0.0 | 
| LAL195 (R) | 1 | ACh | 1 | 0.2% | 0.0 | 
| PAM10 (L) | 1 | DA | 0.5 | 0.1% | 0.0 | 
| PEN_a(PEN1) (R) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| hDeltaG (R) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| hDeltaB (R) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| FB4B (L) | 1 | Unk | 0.5 | 0.1% | 0.0 | 
| OA-AL2i1 (L) | 1 | OA | 0.5 | 0.1% | 0.0 | 
| ER1 (R) | 1 | Unk | 0.5 | 0.1% | 0.0 | 
| FC2B (L) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| SpsP (L) | 1 | Glu | 0.5 | 0.1% | 0.0 | 
| ER3p_a (R) | 1 | GABA | 0.5 | 0.1% | 0.0 | 
| P6-8P9 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 | 
| FC2A (L) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| PAM11 (L) | 1 | DA | 0.5 | 0.1% | 0.0 | 
| FR2 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| FB2A (L) | 1 | DA | 0.5 | 0.1% | 0.0 | 
| FS1A (L) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| PFL3 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 | 
| ER3p_b (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |